Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential.

Stalinska J, Zimolag E, Pianovich NA, Zapata A, Lassak A, Rak M, Dean M, Ucar-Bilyeu D, Wyczechowska D, Culicchia F, Marrero L, Del Valle L, Sarkaria J, Peruzzi F, Jursic BS, Reiss K.

Transl Oncol. 2019 Jul;12(7):895-907. doi: 10.1016/j.tranon.2019.04.006. Epub 2019 May 9.

2.

Anticancer potential of aminomethylidene-diazinanes I. Synthesis of arylaminomethylidene of diazinetriones and its cytotoxic effects tested in glioblastoma cells.

Pianovich NA, Dean M, Lassak A, Reiss K, Jursic BS.

Bioorg Med Chem. 2017 Oct 1;25(19):5068-5076. doi: 10.1016/j.bmc.2017.08.020. Epub 2017 Aug 12.

3.

Synthesis of N-aryl and N-arylcarbamoylamino derivatives of 1,3-diazinane-5-carboxamide and their activity against glioblastoma LN-229 cell line.

Hron RJ, Jursic BS, Neumann DM.

Bioorg Med Chem. 2016 Dec 1;24(23):6183-6193. doi: 10.1016/j.bmc.2016.09.074. Epub 2016 Oct 4.

PMID:
27765409
4.

Potent antimicrobial agents against azole-resistant fungi based on pyridinohydrazide and hydrazomethylpyridine structural motifs.

Backes GL, Jursic BS, Neumann DM.

Bioorg Med Chem. 2015 Jul 1;23(13):3397-407. doi: 10.1016/j.bmc.2015.04.040. Epub 2015 Apr 22.

PMID:
25943854
5.

Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals.

Luna-Tapia A, Kerns ME, Eberle KE, Jursic BS, Palmer GE.

Antimicrob Agents Chemother. 2015 Apr;59(4):2410-20. doi: 10.1128/AAC.04239-14. Epub 2015 Feb 9.

6.

Synthesis and antifungal activity of substituted salicylaldehyde hydrazones, hydrazides and sulfohydrazides.

Backes GL, Neumann DM, Jursic BS.

Bioorg Med Chem. 2014 Sep 1;22(17):4629-36. doi: 10.1016/j.bmc.2014.07.022. Epub 2014 Jul 23.

PMID:
25127462
7.

Synthesis and antifungal activity of substituted 2,4,6-pyrimidinetrione carbaldehyde hydrazones.

Neumann DM, Cammarata A, Backes G, Palmer GE, Jursic BS.

Bioorg Med Chem. 2014 Jan 15;22(2):813-26. doi: 10.1016/j.bmc.2013.12.010. Epub 2013 Dec 12.

PMID:
24361188
8.

Antifungal activity of 2α,3β-functionalized steroids stereoselectively increases with the addition of oligosaccharides.

Cammarata A, Upadhyay SK, Jursic BS, Neumann DM.

Bioorg Med Chem Lett. 2011 Dec 15;21(24):7379-86. doi: 10.1016/j.bmcl.2011.10.015. Epub 2011 Oct 12.

PMID:
22047693
9.

Synthesis and antifungal activity of functionalized 2,3-spirostane isomers.

Upadhyay SK, Creech CC, Bowdy KL, Stevens ED, Jursic BS, Neumann DM.

Bioorg Med Chem Lett. 2011 May 15;21(10):2826-31. doi: 10.1016/j.bmcl.2011.03.092. Epub 2011 Mar 30.

10.

Novel and efficient synthesis and antifungal evaluation of 2,3-functionalized cholestane and androstane derivatives.

Jursic BS, Upadhyay SK, Creech CC, Neumann DM.

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7372-5. doi: 10.1016/j.bmcl.2010.10.044. Epub 2010 Oct 14.

PMID:
21036611
11.

Electrospray-ionization mass spectrometry study of cyclodextrin complexes with A007 prodrugs.

Sagiraju S, Chen K, Cole RB, Jursic BS.

Carbohydr Res. 2009 Nov 2;344(16):2167-72. doi: 10.1016/j.carres.2009.06.042. Epub 2009 Jul 22.

PMID:
19729153
12.

Carbonate and carbamate derivatives of 4-demethylpenclomedine as novel anticancer agents.

Morgan LR, Struck RF, Waud WR, LeBlanc B, Rodgers AH, Jursic BS.

Cancer Chemother Pharmacol. 2009 Sep;64(4):829-35. doi: 10.1007/s00280-009-0933-9. Epub 2009 Mar 3.

13.

NMR spectroscopic study of cyclodextrin inclusion complexes with A-007 prodrugs.

Sagiraju S, Jursic BS.

Carbohydr Res. 2008 May 19;343(7):1180-90. doi: 10.1016/j.carres.2008.03.014. Epub 2008 Mar 14.

PMID:
18384761
14.
15.
16.

Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide.

Germann N, Urien S, Rodgers AH, Ratterree M, Struck RF, Waud WR, Serota DG, Bastian G, Jursic BS, Morgan LR.

Cancer Chemother Pharmacol. 2005 Feb;55(2):143-51. Epub 2004 Sep 14.

PMID:
15592722
17.

Design, synthesis, and anticancer properties of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone and analogues.

Morgan LR, Thangaraj K, LeBlanc B, Rodgers A, Wolford LT, Hooper CL, Fan D, Jursic BS.

J Med Chem. 2003 Oct 9;46(21):4552-63.

PMID:
14521417
18.

Anticancer activity for 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) analogues and their abilities to interact with lymphoendothelial cell surface markers.

Morgan LR, Jursic BS, Hooper CL, Neumann DM, Thangaraj K, LeBlanc B.

Bioorg Med Chem Lett. 2002 Dec 2;12(23):3407-11.

PMID:
12419372
19.

Unique charge-separated pyridinium-barbituric acid zwitterions.

Jursic BS, Neumann DM, Moore Z, Stevens ED.

J Org Chem. 2002 Apr 5;67(7):2372-4.

PMID:
11925259
20.

Barbituric acid initiated rearrangement of 2,2'-pyridil into 5,5'-(2-pyrilidine)bisbarbituric acid.

Jursic BS, Neumann DM, Martin KL, Stevens ED.

Org Lett. 2002 Mar 7;4(5):811-3.

PMID:
11869134
21.

Anticancer properties for 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007)/3,7-diaminophenothiazin-5-ium double salts.

Morgan LR, Rodgers AH, LeBlanc BW, Boué SM, Yang Y, Jursic BS, Cole RB.

Bioorg Med Chem Lett. 2001 Aug 20;11(16):2193-5.

PMID:
11514168
23.

On the mechanism of HOONO to HONO2 conversion.

Jursic BS, Klasinc L, Pecur S, Pryor WA.

Nitric Oxide. 1997;1(6):494-501.

PMID:
9466955
24.

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA.

Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5705-8.

25.

Potent cytodifferentiating agents related to hexamethylenebisacetamide.

Breslow R, Jursic B, Yan ZF, Friedman E, Leng L, Ngo L, Rifkind RA, Marks PA.

Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5542-6.

Supplemental Content

Loading ...
Support Center